Mumbai: Dilip Shanghvi is going ahead with his biggest bet ever, by submitting a binding offer of $13 billion to acquire US-based Organon & Co, said people in the ...
Mumbai: India’s largest drugmaker Sun Pharmaceutical has received a nod from the US Food and Drug Administration (USFDA) to expand the therapeutic use of its innovative drug Ilumya for ...
Overview Working outdoors in the sunlight can increase your risk of sunburn and skin cancer. Ultraviolet (UV) rays are a part of sunlight that is an invisible form of ...
Incremental gains for the company, and the listed pharma universe more broadly, also stemmed from positive sentiment around the India–US trade deal. About a third of Sun Pharma’s revenues ...
Mumbai: India's largest drug maker Sun Pharmaceutical Industries on Saturday said it will adopt a "disciplined" approach to mergers and acquisitions. "We will look at acquisitions only if we ...
Sun Pharmaceutical Industries Ltd, India’s largest drugmaker by market cap and revenue, is evaluating the acquisition of US-based Organon, a specialist in women’s health with an expanding presence in ...
Sun-Moon Conjunction 2026 : ज्योतिष शास्त्र के अनुसार साल 2026 में एक बेहद खास संयोग बनने जा रहा है. 18 जनवरी को मौनी अमावस्या के पावन दिन सूर्य और ...
When astronomers spotted a faint object speeding through the outer Solar System in mid-2025, no one expected it to rewrite parts of cosmic history. The object, now called 3I/ATLAS, ...
Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA (Tildrakizumab) ...